Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Cash: 2013-2025

Historic Change in Cash for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $28.6 million.

  • Amphastar Pharmaceuticals' Change in Cash rose 1044.41% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.1 million, marking a year-over-year increase of 130.69%. This contributed to the annual value of $7.3 million for FY2024, which is 161.96% up from last year.
  • Amphastar Pharmaceuticals' Change in Cash amounted to $28.6 million in Q3 2025, which was up 482.35% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Change in Cash ranged from a high of $119.8 million in Q3 2023 and a low of -$126.5 million during Q4 2023.
  • In the last 3 years, Amphastar Pharmaceuticals' Change in Cash had a median value of $4.9 million in 2025 and averaged $5.5 million.
  • Data for Amphastar Pharmaceuticals' Change in Cash shows a peak YoY increase of 1,443.62% (in 2023) and a maximum YoY decrease of 10,938.92% (in 2023) over the last 5 years.
  • Over the past 5 years, Amphastar Pharmaceuticals' Change in Cash (Quarterly) stood at $19.7 million in 2021, then tumbled by 105.80% to -$1.1 million in 2022, then tumbled by 10,938.92% to -$126.5 million in 2023, then skyrocketed by 67.98% to -$40.5 million in 2024, then soared by 1,044.41% to $28.6 million in 2025.
  • Its last three reported values are $28.6 million in Q3 2025, $4.9 million for Q2 2025, and $31.2 million during Q1 2025.